BCL2 and Parkinson disease: Ginkgetin and bilobalide decrease levels of intracellular ROS, maintain mitochondrial membrane potential, and inhibit cell apoptosis via caspase-3 and Bcl2/Bax pathways to exert antioxidant effects in the mouse model of Parkinson’s disease [64,65].